News & Events

DARPA grants ASU up to $38.8 million to create epigenetic tool for fight against weapons of mass destruction

December 10, 2020

Arizona State University announced today that it has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to build a field-deployable, point-of-care device that will determine in 30 minutes or less if a person has been exposed to weapons of mass destruction or their precursors. The DARPA award, worth up to $38.8 million over four years in phases and options, will build on the university’s growing capabilities in developing molecular diagnostics for applications in...

Evaluating Prognostic Accuracy of Biomarkers for Prostate Cancer Active Surveillance Study

May 16, 2018

Yunro “Roy” Chung, Ph. D., Public Health Sciences Division, Fred Hutchinson Cancer Research Center Active Surveillance for patients diagnosed with low-grade cancer has become a population management strategy for reducing overtreatment. Novel biomarkers have been sought for decision making during Active Surveillance. The accuracy of the decision tools for such a purpose needs to be quantified. The evaluation can be challenging due to the lack of definite measurement of outcomes on all...